BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 12195387)

  • 1. Escherichia coli O157 fails to induce a long-lasting lipopolysaccharide-specific, measurable humoral immune response in children with hemolytic-uremic syndrome.
    Ludwig K; Bitzan M; Bobrowski C; Müller-Wiefel DE
    J Infect Dis; 2002 Aug; 186(4):566-9. PubMed ID: 12195387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saliva IgM and IgA are a sensitive indicator of the humoral immune response to Escherichia coli O157 lipopolysaccharide in children with enteropathic hemolytic uremic syndrome.
    Ludwig K; Grabhorn E; Bitzan M; Bobrowski C; Kemper MJ; Sobottka I; Laufs R; Karch H; Müller-Wiefel DE
    Pediatr Res; 2002 Aug; 52(2):307-13. PubMed ID: 12149511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serological investigations on patients with hemolytic uremic syndromes due to enterohemorrhagic Escherichia coli O157:H7 infection].
    Xu J; Cheng B; Feng L; Jing H; Yang J; Zhao G; Wang H; Li H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2002 Apr; 23(2):114-8. PubMed ID: 12015093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The serological response to Verocytotoxigenic Escherichia coli in patients with haemolytic uraemic syndrome.
    Chart H; Perry NT
    Lett Appl Microbiol; 2004; 38(5):351-4. PubMed ID: 15059202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings.
    Banatvala N; Griffin PM; Greene KD; Barrett TJ; Bibb WF; Green JH; Wells JG;
    J Infect Dis; 2001 Apr; 183(7):1063-70. PubMed ID: 11237831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble Fas and soluble Fas-ligand in children with Escherichia coli O157:H7-associated hemolytic uremic syndrome.
    Masri C; Proulx F; Toledano B; Clermont MJ; Mariscalco MM; Seidman EG; Carcillo J
    Am J Kidney Dis; 2000 Oct; 36(4):687-94. PubMed ID: 11007669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Enterohemorrhagic Escherichia coli in hemolytic uremic syndrome in Chilean children. Evaluation of different technics in the diagnosis of the infection].
    Prado V; Cordero J; Garreaud C; Olguin H; Arellano C; Nachar CL; Misraji A; Martínez J; Tous M; Rivas M
    Rev Med Chil; 1995 Jan; 123(1):13-22. PubMed ID: 7569441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral immune responses to Shiga-like toxins and Escherichia coli O157 lipopolysaccharide in hemolytic-uremic syndrome patients and healthy subjects.
    Greatorex JS; Thorne GM
    J Clin Microbiol; 1994 May; 32(5):1172-8. PubMed ID: 8051241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of usefulness of the enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to lipopolysaccharides of Enterohemorrhagic Escherichia coli (EHEC) strains in patients with gastrointestinal disorders and patients with hemolytic uremic syndrome].
    Med Dosw Mikrobiol; 2014; 66(3-4):161-75. PubMed ID: 25804070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verocytotoxin-producing Escherichia coli in children with hemolytic uremic syndrome in the Czech Republic.
    Bielaszewska M; Janda J; Blahová K; Feber J; Potuzník V; Soucková A
    Clin Nephrol; 1996 Jul; 46(1):42-4. PubMed ID: 8832150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to lipopolysaccharide block adherence of Shiga toxin-producing Escherichia coli to human intestinal epithelial (Henle 407) cells.
    Paton AW; Voss E; Manning PA; Paton JC
    Microb Pathog; 1998 Jan; 24(1):57-63. PubMed ID: 9466947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota.
    Smith KE; Wilker PR; Reiter PL; Hedican EB; Bender JB; Hedberg CW
    Pediatr Infect Dis J; 2012 Jan; 31(1):37-41. PubMed ID: 21892124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isotype-specific antibody responses against Escherichia coli O157:H7 locus of enterocyte effacement proteins in adult beef cattle following experimental infection.
    Bretschneider G; Berberov EM; Moxley RA
    Vet Immunol Immunopathol; 2007 Aug; 118(3-4):229-38. PubMed ID: 17617472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating granulocyte colony-stimulating factor, C-X-C, and C-C chemokines in children with Escherichia coli O157:H7 associated hemolytic uremic syndrome.
    Proulx F; Toledano B; Phan V; Clermont MJ; Mariscalco MM; Seidman EG
    Pediatr Res; 2002 Dec; 52(6):928-34. PubMed ID: 12438672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic antibody response to diarrheagenic Escherichia coli and LPS O111, O157 and O55 in healthy Brazilian adults.
    Zapata-Quintanilla LB; Palmeira P; Tino-De-Franco M; Amaral JA; Carbonare CB; Carbonare SB
    Scand J Immunol; 2006 Dec; 64(6):661-7. PubMed ID: 17083623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquisition of serum antibodies reactive with enterohemorrhagic Escherichia coli virulence-associated factors by healthy Brazilian children and adults.
    Palmeira P; Carbonare SB; Guth BE; Carbonare CB; Pontes GN; Tino-De-Franco M; Zapata-Quintanilla LB; Carneiro-Sampaio M
    Pediatr Infect Dis J; 2009 Dec; 28(12):1089-94. PubMed ID: 19755927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verocytotoxigenic Escherichia coli serologic responses in patients with hemolytic uremic syndrome.
    Goldwater PN; Bettelheim KA
    J Infect Dis; 2002 Aug; 186(4):582; author reply 582-3. PubMed ID: 12195391
    [No Abstract]   [Full Text] [Related]  

  • 19. Mucosal and systemic antibody responses to the lipopolysaccharide of Escherichia coli O157 in health and disease.
    Currie CG; McCALLUM K; Poxton IR
    J Med Microbiol; 2001 Apr; 50(4):345-354. PubMed ID: 11289520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies among healthy population of developing countries against enterohaemorrhagic Escherichia coli O157:H7.
    Voravuthikunchai SP; Chaowana C; Perepat P; Iida T; Honda T
    J Health Popul Nutr; 2005 Dec; 23(4):305-10. PubMed ID: 16599100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.